CD89 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD89 monoclonal antibodies for advanced research in immunology and cell biology. CD89 monoclonal antibodies perform effectively in multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD89, also known as the IgA Fc receptor, plays a crucial role in the immune response by mediating the functions of IgA antibodies, which are essential for mucosal immunity. The receptor is involved in processes such as phagocytosis, antibody-dependent cellular cytotoxicity, and the regulation of immune cell activation. Understanding CD89 function is vital for developing therapeutic strategies against various diseases, including infections and autoimmune disorders. Researchers worldwide utilize CD89 monoclonal antibodies to investigate immune system responses and cellular pathways. The detailed characterization of CD89 continues to reveal new insights into immune regulation and disease mechanisms. CD89 monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific understanding of immune system function and potential therapeutic applications.